RCUS R&D to Revenue
Arcus Biosciences Inc · R&D to Revenue
RCUS R&D to Revenue
Latest reported211.74%period ending
RCUS FY R&D/Revenue (0.00% → 211.74%)
Latest values, visible window
High-resolution chart · PNG
RCUS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 211.7409% | |
| 173.6434% | |
| 290.5983% | |
| 257.1429% | |
| 67.1018% | |
| 203.8462% | |
| 523.2067% | |
| 594.3493% | |
| 3,341.6844% | |
| 0% |